Oral P2Y12 inhibitor pretreatment offers no benefit in non-ST elevation acute coronary syndromes
1. Pretreatment with oral P2Y12 inhibitors in patients with non-ST elevation acute coronary syndromes demonstrated no reduction in major cardiovascular ...